LadRx (OTCMKTS:CYTR) and PharmaCyte Biotech (NASDAQ:PMCB) Financial Review
Institutional and Insider Ownership 0.1% of LadRx shares are owned by institutional investors. Comparatively, 34.2% of PharmaCyte Biotech shares are owned by institutional investors. 12.8% of LadRx shares are owned by company insiders. Comparatively, 10.2% of PharmaCyte Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge […]
Institutional and Insider Ownership 0.1% of LadRx shares are owned by institutional investors. Comparatively, 34.2% of PharmaCyte Biotech shares are owned by institutional investors. 12.8% of LadRx shares are owned by company insiders. Comparatively, 10.2% of PharmaCyte Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge […]
